
Congress trades
Baxter International Inc. (BAX)
NYSE · Healthcare · 360 insider transactions · 124 congress trades · last filed 2 months agoS&P 500
About Baxter International Inc.
from the company's filings and listing, as of Oct 25, 2026- Exchange
- NYSE
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- Chief executive
- Andrew Hider
- Employees
- 37,500
- Listed since
- Oct 27, 1981
- Market value
- $13.1B
- Price to earnings (12 mo)
- -
- Net income per share, as reported (12 mo)
- -$2.06
- Dividend yield
- 0.16%
Earnings
6 reported quarters · next on Oct 29, 2026| Quarter | EPS | EPS expected | Revenue | Revenue expected | Result |
|---|---|---|---|---|---|
| Q2 FY2026reported Jul 30, 2026 | $0.56 | $0.37 | $3.0B | $2.8B | EPS beatRevenue beat |
| Q1 FY2026reported Apr 30, 2026 | $0.36 | $0.31 | $2.7B | $2.6B | EPS beatRevenue beat |
| Q4 FY2025reported Feb 12, 2026 | $0.44 | $0.53 | $3.0B | $2.8B | EPS missRevenue beat |
| Q3 FY2025reported Oct 30, 2025 | $0.69 | $0.60 | $2.8B | $2.8B | EPS beatRevenue in line |
| Q2 FY2025reported Jul 31, 2025 | $0.59 | $0.60 | $2.8B | $2.9B | EPS missRevenue miss |
| Q1 FY2025reported May 1, 2025 | $0.55 | $0.48 | $2.6B | $2.6B | EPS beatRevenue in line |
Actual against the consensus estimate at the time. A flag marks a beat or a miss of more than 1.5% either way; inside that band the quarter is in line. A flag reads n/a only when a number is missing. Quarterly EPS is the figure set against the consensus, usually adjusted, so the quarters need not add up to the 12-month net income per share above. An estimate is a forecast made by analysts, not a company target.
Executive pay
as filed for fiscal 2025 · proxy filed Mar 23, 2026| Executive | Salary | Stock awards | Other | Total |
|---|---|---|---|---|
| Reazur RasulExecutive Vice President and Group President, Healthcare Systems & Technologies | $800K | $3.0M | $1.5M | $5.2M |
The summary compensation table from the proxy statement for fiscal 2025, with titles as filed then. 3 executives who have since left the company are named in that filing and not shown here. Read the filing
Institutional holders
13F positions as of Jun 30, 2026| Holder | Value | Shares | Shares vs prior qtr | % of shares out |
|---|---|---|---|---|
| BlackRock, Inc. | $1.7B | 81,842,105 | +3.1% | 15.83% |
| Pzena Investment Management LLC | $1.4B | 65,295,393 | +1.2% | 12.63% |
| Dodge & Cox | $1.2B | 58,386,345 | +2.0% | 11.29% |
| FMR LLC | $1.1B | 53,913,831 | +16.5% | 10.43% |
| Vanguard Capital Management LLC | $719.6M | 33,754,280 | +0.7% | 6.53% |
| Vanguard Portfolio Management LLC | $512.9M | 24,057,190 | +0.3% | 4.65% |
| State Street Corp | $439.4M | 20,600,468 | +3.1% | 4.00% |
| Greenhaven Associates Inc | $304.6M | 14,285,228 | -0.2% | 2.76% |
| Geode Capital Management, LLC | $300.6M | 14,123,689 | +2.6% | 2.73% |
| Invesco Ltd. | $263.6M | 12,361,881 | -5.8% | 2.39% |
| UBS Group AG | $203.2M | 9,529,309 | +120.6% | 1.84% |
| First Pacific Advisors, LP | $162.4M | 7,618,145 | +13.7% | 1.47% |
A 13F reports long US equity positions and is filed within 45 days of the quarter end, so these are positions as they stood on Jun 30, 2026. For a manager's whole book see the fund directory. What a 13F covers and leaves out is explained in our guide to Form 13F.
Other Form 4 activity (20)
| Insider | Event | Shares | Date |
|---|---|---|---|
| Julie FosterPresident, Front Line Care | Tax withholding | 2,098 | Sep 2, 2026 |
| Andrew P. HiderPresident and CEO | Tax withholding | 54,276 | Sep 2, 2026 |
| James TeaffPresident, CCS | Tax withholding | 750 | Sep 1, 2026 |
| William A. Ampofo IIDirector | Stock award | 12,836 | May 5, 2026 |
| Jeffrey A. CraigDirector | Stock award | 12,836 | May 5, 2026 |
| Michael R. McDonnellDirector | Stock award | 12,836 | May 5, 2026 |
| David Brent ShaferDirector | Stock award | 12,836 | May 5, 2026 |
| Patricia MorrisonDirector | Stock award | 12,836 | May 5, 2026 |
| Nancy M. SchlichtingDirector | Stock award | 12,836 | May 5, 2026 |
| Amy McBride WendellDirector | Stock award | 12,836 | May 5, 2026 |
| David S. WilkesDirector | Stock award | 12,836 | May 5, 2026 |
| James TeaffPresident, CCS | Other Form 4 entry (see filing) | 55,119 | Apr 1, 2026 |
| Steven P. WallacePresident, Adv. Surgery | Other Form 4 entry (see filing) | 67,972 | Apr 1, 2026 |
| Julie FosterPresident, Front Line Care | Other Form 4 entry (see filing) | 25,862 | Apr 1, 2026 |
| Joel T. GradeEVP and CFO | Tax withholding | 8,153 | Mar 6, 2026 |
| Reazur RasulEVP, Group Pres, Healthcare | Tax withholding | 12,674 | Mar 6, 2026 |
| David S. RosenbloomEVP and General Counsel | Tax withholding | 6,620 | Mar 6, 2026 |
| Maria Cecilia SorianoGroup Pres., ITT & Pharma. | Tax withholding | 2,848 | Mar 6, 2026 |
| Anita A. ZielinskiSVP, CAO and Controller | Tax withholding | 1,932 | Mar 6, 2026 |
| Anita A. ZielinskiSVP, CAO and Controller | Stock award | 30,864 | Feb 27, 2026 |
Awards, option exercises, shares withheld to cover tax and gifts all file on the same form as a purchase or a sale. None of them is a decision to trade, so they sit here rather than beside the ones that are.
Congress trades in BAX
20 disclosures of 124 on record · median 24d of the 45 allowedSince the trade: the stock's move from the trade date to the latest close we hold (figures as of Oct 25, 2026), not the member's result. Not investment advice.
| Member | Type | Action | Amount disclosed | Stock since the trade | Trade date | Disclosed | Delay |
|---|---|---|---|---|---|---|---|
| Ro Khanna | Stock | Purchase | $1,001 - $15,000 | +47.0%S&P 500 +5.4% · +41.6 pts vs S&P 500 | May 1, 2026 | Jun 9, 2026 | 39d |
| Ro Khanna | Stock | Purchase | $1,001 - $15,000 | +46.2%S&P 500 +2.8% · +43.4 pts vs S&P 500 | May 15, 2026 | Jun 9, 2026 | 25d |
| Ro Khanna | Stock | Purchase | $1,001 - $15,000 | +30.9%S&P 500 +1.3% · +29.6 pts vs S&P 500 | May 27, 2026 | Jun 9, 2026 | 13d |
| Ro Khanna | Stock | Sale | $1,001 - $15,000 | +39.3%After the saleS&P 500 +6.4% · +32.9 pts vs S&P 500 | Apr 24, 2026 | May 11, 2026 | 17d |
| Ro Khanna | Stock | Sale | $1,001 - $15,000 | +43.5%After the saleS&P 500 +10.8% · +32.8 pts vs S&P 500 | Apr 13, 2026 | May 11, 2026 | 28d |
| Ro Khanna | Stock | Sale | $1,001 - $15,000 | +60.1%After the saleS&P 500 +20.3% · +39.9 pts vs S&P 500 | Mar 30, 2026 | Apr 7, 2026 | 8d |
| Michael T. McCaul | Stock | Purchase | $100,001 - $250,000 | +22.0%S&P 500 +11.2% · +10.8 pts vs S&P 500 | Feb 17, 2026 | Mar 10, 2026 | 21d |
| Ro Khanna | Stock | Purchase | $1,001 - $15,000 | +22.0%S&P 500 +11.2% · +10.8 pts vs S&P 500 | Feb 17, 2026 | Mar 9, 2026 | 20d |
| Michael T. McCaul | Stock | Purchase | $50,001 - $100,000 | +28.8%S&P 500 +9.5% · +19.3 pts vs S&P 500 | Jan 13, 2026 | Feb 11, 2026 | 29d |
| Ro Khanna | Stock | Purchase | $1,001 - $15,000 | +30.0%S&P 500 +10.0% · +20.0 pts vs S&P 500 | Jan 29, 2026 | Feb 6, 2026 | 8d |
| Ro Khanna | Stock | Sale | $1,001 - $15,000 | +42.5%After the saleS&P 500 +11.5% · +31.0 pts vs S&P 500 | Nov 10, 2025 | Dec 8, 2025 | 28d |
| Lisa C. McClainSpouse | Stock | Purchase | $1,001 - $15,000 | +32.1%S&P 500 +11.7% · +20.3 pts vs S&P 500 | Oct 30, 2025 | Nov 21, 2025 | 22d |
| Lisa C. McClainSpouse | Stock | Sale | $1,001 - $15,000 | +32.1%After the saleS&P 500 +11.7% · +20.3 pts vs S&P 500 | Oct 30, 2025 | Nov 21, 2025 | 22d |
| Lisa C. McClainSpouse | Stock | Sale | $1,001 - $15,000 | +37.0%After the saleS&P 500 +11.4% · +25.6 pts vs S&P 500 | Oct 31, 2025 | Nov 21, 2025 | 21d |
| Lisa C. McClainSpouse | Stock | Purchase | $1,001 - $15,000 | +16.5%S&P 500 +15.2% · +1.4 pts vs S&P 500 | Sep 25, 2025 | Oct 22, 2025 | 27d |
| Ro Khanna | Stock | Sale | $1,001 - $15,000 | +7.5%After the saleS&P 500 +18.1% · -10.6 pts vs S&P 500 | Sep 3, 2025 | Oct 3, 2025 | 30d |
| Ro Khanna | Stock | Sale | $1,001 - $15,000 | +3.6%After the saleS&P 500 +17.4% · -13.8 pts vs S&P 500 | Sep 5, 2025 | Oct 3, 2025 | 28d |
| Ro Khanna | Stock | Purchase | $1,001 - $15,000 | +13.1%S&P 500 +14.5% · -1.4 pts vs S&P 500 | Sep 29, 2025 | Oct 3, 2025 | 4d |
| Lisa C. McClainSpouse | Stock | Sale | $1,001 - $15,000 | +12.8%After the saleS&P 500 +20.4% · -7.7 pts vs S&P 500 | Aug 4, 2025 | Sep 12, 2025 | 39d |
| Ro Khanna | Stock | Purchase | $1,001 - $15,000 | +12.8%S&P 500 +20.4% · -7.7 pts vs S&P 500 | Aug 4, 2025 | Sep 9, 2025 | 36d |
Since the trade is an estimate, set beside the S&P 500 over the same window, with the gap between the two in percentage points. The filing carries a band, not a fill, and a sale keeps the stock's sign, so a positive figure after a sale means the stock kept rising after it. An option row carries the underlying stock's move. A row marked n/a is one we hold no figure for.
A delay above 45 days is the gap between the dates on the report; we mark a filing late only after checking it.
"Not captured" means the band or the transaction type on the original report is missing from our data.
"Dates conflict" marks a row whose disclosure is dated before its trade on the record we hold. Both dates are printed as filed, and no since-the-trade figure is computed from them.
Every Congress trade in BAX, filterable by party, chamber, type and account.
Members of Congress reporting a position
3 members · estimate, as of Oct 24, 20263 members report a position (estimated). The largest estimated position is in the $1,001 - $15,000 band.
| Member | Party, chamber | Estimated position | Share of their portfolio |
|---|---|---|---|
| Lucy McBath | Democrat · House | $1,001 - $15,000 | 0.2% |
| Robert Bresnahan | Republican · House | $1,001 - $15,000 | 0.1% |
| Debbie Wasserman Schultz | Democrat · House | $1,001 - $15,000 | 22.6% |
Estimate, as of Oct 24, 2026. Each position is modelled from the member's disclosed transactions and annual filings: the midpoint of each disclosed band, moved with the stock's price since the trade. It is a rough estimate of a reported position, not a figure from a filing, which is why it is shown as a band. Share of portfolio sets that estimate against the member's whole estimated public-stock portfolio.
Questions
Which members of Congress have traded BAX?
Ro Khanna, Michael T. McCaul and Lisa C. McClain disclosed BAX transactions in the filings shown here.
Which members of Congress hold BAX?
3 members of Congress report a position in BAX in the estimate we hold as of Oct 24, 2026. The estimated positions belong to Lucy McBath, Robert Bresnahan and Debbie Wasserman Schultz. The estimate is built from disclosed transactions and annual filings, so it is shown as a band rather than a figure from a filing.
Is BAX in the S&P 500 or the Nasdaq 100?
Baxter International Inc. is a current member of the S&P 500, per the membership list we hold as of Oct 26, 2026. Current members of either index get a page here whatever their filing history.
How quickly are BAX trades disclosed?
Congressional disclosures took a median of 24 days, against the 45 the STOCK Act allows.
How to read a STOCK Act filing
WHAT THE FILING ACTUALLY SAYS
Congress rows disclose a value range rather than an exact amount, and the STOCK Act allows up to 45 days to report. Full sourcing and the limits of this data are on the methodology page. A filing is a record of a transaction, not a signal, and nothing here is investment advice.
Data as of Oct 26, 2026.
